OpenURL Connection Search

Select item for more details and to access through your institution.

A phase 1 study evaluating safety and pharmacokinetics of losatuxizumab vedotin (ABBV-221), an anti-EGFR antibody-drug conjugate carrying monomethyl auristatin E, in patients with solid tumors likely to overexpress EGFR.
Published in:
Investigational New Drugs, 2020, v. 38, n. 5, p. 1483, doi. 10.1007/s10637-020-00908-3
By:
- Cleary, James M.;
- Calvo, Emiliano;
- Moreno, Victor;
- Juric, Dejan;
- Shapiro, Geoffrey I.;
- Vanderwal, Carol Ann;
- Hu, Beibei;
- Gifford, Maryella;
- Barch, David;
- Roberts-Rapp, Lisa;
- Ansell, Peter J.;
- Xiong, Hao;
- Ocampo, Christopher;
- Tolcher, Anthony W.
Publication type:
Article
The Effects of SOM230 on Cell Proliferation and Adrenocorticotropin Secretion in Human Corticotroph Pituitary Adenomas.
Published in:
Journal of Clinical Endocrinology & Metabolism, 2006, v. 91, n. 11, p. 4482, doi. 10.1210/jc.2006-1245
By:
- Batista, Dalia L.;
- Xun Zhang;
- Gejman, Roger;
- Ansell, Peter J.;
- Yunli Zhou;
- Johnson, Sarah A.;
- Swearingen, Brooke;
- Hedley-Whyte, E. Tessa;
- Stratakis, Constantine A.;
- Klibanski, Anne
Publication type:
Article
Matched cohort study of germline BRCA mutation carriers with triple negative breast cancer in brightness.
Published in:
NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-021-00349-y
By:
- Metzger-Filho, Otto;
- Collier, Katharine;
- Asad, Sarah;
- Ansell, Peter J.;
- Watson, Mark;
- Bae, Junu;
- Cherian, Mathew;
- O'Shaughnessy, Joyce;
- Untch, Michael;
- Rugo, Hope S.;
- Huober, Jens B.;
- Golshan, Mehra;
- Sikov, William M.;
- von Minckwitz, Gunter;
- Rastogi, Priya;
- Li, Lang;
- Cheng, Lijun;
- Maag, David;
- Wolmark, Norman;
- Denkert, Carsten
Publication type:
Article
Safety and efficacy of depatuxizumab mafodotin + temozolomide in patients with EGFR-amplified, recurrent glioblastoma: results from an international phase I multicenter trial.
Published in:
Neuro-Oncology, 2019, v. 21, n. 1, p. 106, doi. 10.1093/neuonc/noy091
By:
- Lassman, Andrew B;
- Bent, Martin J van den;
- Gan, Hui K;
- Reardon, David A;
- Kumthekar, Priya;
- Butowski, Nicholas;
- Lwin, Zarnie;
- Mikkelsen, Tom;
- Nabors, Louis B;
- Papadopoulos, Kyriakos P;
- Penas-Prado, Marta;
- Simes, John;
- Wheeler, Helen;
- Walbert, Tobias;
- Scott, Andrew M;
- Gomez, Erica;
- Lee, Ho-Jin;
- Roberts-Rapp, Lisa;
- Xiong, Hao;
- Ansell, Peter J
Publication type:
Article
Safety, pharmacokinetics, and antitumor response of depatuxizumab mafodotin as monotherapy or in combination with temozolomide in patients with glioblastoma.
Published in:
Neuro-Oncology, 2018, v. 20, n. 6, p. 838, doi. 10.1093/neuonc/nox202
By:
- Gan, Hui K.;
- Reardon, David A.;
- Lassman, Andrew B.;
- Merrell, Ryan;
- van den Bent, Martin;
- Butowski, Nicholas;
- Lwin, Zarnie;
- Wheeler, Helen;
- Fichtel, Lisa;
- Scott, Andrew M.;
- Gomez, Erica J.;
- Fischer, JuDee;
- Mandich, Helen;
- Hao Xiong;
- Ho-Jin Lee;
- Munasinghe, Wijith P.;
- Roberts-Rapp, Lisa A.;
- Ansell, Peter J.;
- Holen, Kyle D.;
- Kumthekar, Priya
Publication type:
Article
ABBV-176, a PRLR antibody drug conjugate with a potent DNA-damaging PBD cytotoxin and enhanced activity with PARP inhibition.
Published in:
2021
By:
- Anderson, Mark G.;
- Zhang, Qian;
- Rodriguez, Luis E.;
- Hecquet, Claudie M.;
- Donawho, Cherrie K.;
- Ansell, Peter J.;
- Reilly, Edward B.
Publication type:
journal article
Efficacy and safety results of depatuxizumab mafodotin (ABT-414) in patients with advanced solid tumors likely to overexpress epidermal growth factor receptor.
Published in:
2018
By:
- Goss, Glenwood D.;
- Vokes, Everett E.;
- Gordon, Michael S.;
- Gandhi, Leena;
- Papadopoulos, Kyriakos P.;
- Rasco, Drew W.;
- Fischer, JuDee S.;
- Chu, Katharine L.;
- Ames, William W.;
- Mittapalli, Rajendar K.;
- Lee, Ho‐Jin;
- Zeng, Jiewei;
- Roberts‐Rapp, Lisa A.;
- Loberg, Lise I.;
- Ansell, Peter J.;
- Reilly, Edward B.;
- Ocampo, Christopher J.;
- Holen, Kyle D.;
- Tolcher, Anthony W.;
- Lee, Ho-Jin
Publication type:
journal article
Epidermal growth factor receptor (EGFR) amplification rates observed in screening patients for randomized trials in glioblastoma.
Published in:
Journal of Neuro-Oncology, 2019, v. 144, n. 1, p. 205, doi. 10.1007/s11060-019-03222-y
By:
- Lassman, Andrew B.;
- Aldape, Kenneth D.;
- Ansell, Peter J.;
- Bain, Earle;
- Curran, Walter J.;
- Eoli, Marica;
- French, Pim J.;
- Kinoshita, Manabu;
- Looman, Jim;
- Mehta, Minesh;
- Muragaki, Yoshihiro;
- Narita, Yoshitaka;
- Ocampo, Christopher;
- Roberts-Rapp, Lisa;
- Song, Minghao;
- Vogelbaum, Michael A.;
- Walenkamp, Annemiek M. E.;
- Wang, Tony J. C.;
- Zhang, Peixin;
- van den Bent, Martin J.
Publication type:
Article
Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial.
Published in:
Neuro-Oncology, 2023, v. 25, n. 2, p. 339, doi. 10.1093/neuonc/noac173
By:
- Lassman, Andrew B;
- Pugh, Stephanie L;
- Wang, Tony J C;
- Aldape, Kenneth;
- Gan, Hui K;
- Preusser, Matthias;
- Vogelbaum, Michael A;
- Sulman, Erik P;
- Won, Minhee;
- Zhang, Peixin;
- Moazami, Golnaz;
- Macsai, Marian S;
- Gilbert, Mark R;
- Bain, Earle E;
- Blot, Vincent;
- Ansell, Peter J;
- Samanta, Suvajit;
- Kundu, Madan G;
- Armstrong, Terri S;
- Wefel, Jeffrey S
Publication type:
Article

Found: 9